2005
DOI: 10.1016/j.jpba.2005.04.019
|View full text |Cite
|
Sign up to set email alerts
|

Kinetic study of CYP3A4 activity on verapamil by capillary electrophoresis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
7
0

Year Published

2006
2006
2013
2013

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 15 publications
(7 citation statements)
references
References 24 publications
0
7
0
Order By: Relevance
“…Verapamil is a commonly used marker substrate of CYP3A4 activity, its predominant metabolites being 2‐(3,4‐dimethoxyphenyl)‐5‐methylamino‐2‐isopropylvaleronitrile (D‐617) and norverapamil via N ‐dealkylation and N ‐demethylation, respectively 34–37. An off‐line CE assay assessing CYP3A4 activity with verapamil as a probe substrate was developed in our lab previously 38 and adopted in this study with some small changes. Capillary length was shortened to reduce analysis time.…”
Section: Resultsmentioning
confidence: 99%
“…Verapamil is a commonly used marker substrate of CYP3A4 activity, its predominant metabolites being 2‐(3,4‐dimethoxyphenyl)‐5‐methylamino‐2‐isopropylvaleronitrile (D‐617) and norverapamil via N ‐dealkylation and N ‐demethylation, respectively 34–37. An off‐line CE assay assessing CYP3A4 activity with verapamil as a probe substrate was developed in our lab previously 38 and adopted in this study with some small changes. Capillary length was shortened to reduce analysis time.…”
Section: Resultsmentioning
confidence: 99%
“…However, the Michaelis parameters can only be compared with values obtained using the same enzyme source and identical conditions in the enzymatic assay. Even using the same source of enzyme, different batches can produce different results . In that work, baculovirus‐expressed human CYP enzymes, prepared following a published procedure, were used and the experimental conditions of the assay were very different from ours (see Section ).…”
Section: Resultsmentioning
confidence: 99%
“…Preliminary experiments were performed with the classic CYP metabolic assay approach, by measuring the formation of reaction products, the metabolites [4,6]. R-Warfarin and verapamil were chosen as model substrates for CYP3A4.…”
Section: Preliminary Conditionsmentioning
confidence: 99%
“…The separation conditions were as follows: capillary, 80. In the case of verapamil, CYP3A4 activity was determined by the quantitation of the product, norverapamil, based on separation by CE with UV detection [6]. The separation conditions were as follows: capillary, 80.5 cm (75 mm id, 72 cm effective length); 50 mM sodium phosphate buffer (pH 8.8); 20 kV (100 mA) applied voltage; UV, 200 nm; capillary temperature, 257C.…”
Section: Preliminary Conditionsmentioning
confidence: 99%